News
High-dose dazucorilant patients who went into the open-label extension saw an 84% lower risk of death over those who didn't ...
Seven years after her late husband was diagnosed with ALS, columnist Juliet Taylor writes on how she can't accept much about ...
An implanted brain-computer interface allowed a man with ALS to speak in real time, and sing simple melodies, per a study.
Brainstorm tapped Minaris to manufacture NurOwn for its upcoming Phase 3b clinical trial testing the treatment for ALS.
Struggling with the emotions surrounding her husband's ALS, columnist Kristin Neva tried using ChatGPT as therapy. Here's how ...
A bipartisan team of U.S. legislators in Congress is calling for increased funding to support research into new treatments ...
The FDA has granted fast track designation to Amylyx's experimental therapy AMX0114 for the treatment of amyotrophic lateral ...
Usnoflast is an orally available small molecule that's designed to reduce inflammation, a key contributor to nerve cell ...
Jacifusen was generally well tolerated and reversed disease progression in some people with ALS caused by mutations in the ...
Searching for wisdom, columnist Kristin Neva realizes that living with ALS involves being stripped of a lot of things — like ...
After auditing her daily schedule to improve productivity, columnist Dagmar Munn realizes that her time is actually well ...
The Everylife Foundation for Rare Diseases is offering a new scholarship for U.S. students from the ALS community facing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results